Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.

Adam S KittaiYing HangSeema A BhatAbi ClarkMichael GreverJoanna M RhodesMelyssa RobertsKerry A RogersAnna TeschemakerMaria Munoz-SagastibelzaJennifer A WoyachJacqueline C Barrientos

Published in: American journal of hematology (2024)

Kaplan-Meier curve depicting overall survival from CLL treatment start by race. For patients with CLL, no overall survival difference was observed between races in this real-world US database.

Keyphrases

chronic lymphocytic leukemia
small molecule
free survival
diffuse large b cell lymphoma
protein protein
healthcare
combination therapy
affordable care act
health insurance